Introduction {#Sec1}
============

Liver transplantation (LT) is regarded as a reliable treatment for patients with end-stage liver disease \[[@CR1], [@CR2]\]; however, because of the need for immunosuppressants, various postoperative complications are common including infection \[[@CR3]\]. Among the possible infectious complications after LT, septic pulmonary embolism (SPE) is a rare pathogenesis. SPE is characterized by fever, respiratory symptoms, and lung infiltrates, and is associated with extrapulmonary infections \[[@CR4], [@CR5]\]. SPE is serious condition because it can lead to the development of lung abscesses and empyema \[[@CR5]\]. Here we report on a patient with SPE originating from a subcutaneous abscess following living-donor (LD) LT. The course of this case has important implications for postoperative management after LDLT.

Case report {#Sec2}
===========

A 49-year-old male underwent LDLT because of primary sclerosing cholangitis. Preoperative performance score was 1 and the model for end-stage liver disease score was 24.8. The patient had a history of total colectomy because of ulcerative colitis. The donor was the patient's wife, and the blood types were identical. A right hemiliver graft was used. Graft size was 750 g and the ratio of graft volume/standard liver volume of the recipient was 52.1 %. The cold and warm ischemic time was 111 and 56 min, respectively. Duct-to-duct anastomosis was adopted for biliary reconstruction because postoperative management of strictures is easy to perform by endoscopic methods. Splenectomy was also performed because of preoperative thrombocytopenia resulting from splenomegaly. Expected amount of bleeding was 29,876 ml. He was treated with tacrolimus, mycophenolate mofetil, and steroids as immunosuppressants. The whole-blood trough level of tacrolimus was adjusted to 10--12 ng/ml during the first postoperative week, and was tapered thereafter. The mycophenolate mofetil doses ranged from 500 to 1,000 mg/day. Methylprednisolone (700 mg) was administered twice intraoperatively, tapered gradually thereafter, and discontinued on postoperative day (POD) 35. The patient was discharged on POD 40.

He was re-admitted on POD 48 because of severe acute cellular rejection. After three courses of steroid pulse therapy using methylprednisolone (each comprising 500 mg per session for 3 days; total dose of 4.5 g of methylprednisolone) were performed, the liver dysfunction gradually improved (Fig. [1](#Fig1){ref-type="fig"}); however, continuous peripheral intravenous drip infusion therapy via the left forearm was necessary for 20 days because of appetite loss. The patient was discharged on POD 83; however, he visited our hospital on POD 87 complaining of pyrexia accompanying pain in the left forearm. Laboratory results showed a peripheral white blood cell count of 4,000/mm^3^ with 22.0 % stab cells, C-reactive protein (CRP) levels of 10.3 mg/dl and albumin level of 2.4 g/dl. Liver function tests, including alanine aminotransferase (ALT) measurements, were almost within the normal range (Fig. [1](#Fig1){ref-type="fig"}). Rubefaction accompanying the subcutaneous abscess was present at a wound on the left forearm formed by intravenous drip therapy during the last hospital stay (Fig. [2](#Fig2){ref-type="fig"}). Although respiratory symptoms were not present and performance status was zero, chest computed tomography (CT) revealed five pieces of cavitary or wedge-shaped nodules in the periphery of the bilateral lung (Fig. [3](#Fig3){ref-type="fig"}). The lung nodules ranged from 0.8−2 cm in diameter, and were indistinct on a chest X-ray. β-[d]{.smallcaps} glucan levels were \<6.0 pg/ml, *Aspergillus* antigens were not detected and mycobacterial culture of sputum was negative. The smear from the incisional drainage of the skin, blood and sputum revealed the presence of Gram-positive coccus; empiric broad-spectrum intravenous antibiotics using vancomycin (2 g/day) were thus started immediately. Lastly, methicillin-sensitive *Staphylococcus aureus* was cultured both from the blood and the subcutaneous abscess of the left forearm.Fig. 1Postoperative clinical course showing ALT and CRP levels, and tacrolimus trough level. Treatment courses and hospital admission periods are also shownFig. 2Rubefaction accompanying a subcutaneous abscess (*arrow*) was present at the wound on the left forearm (*arrowhead*) formed by intravenous drip therapy during the last hospital stayFig. 3Chest CT showing five pieces of cavitary or wedge-shaped nodules in the bilateral area periphery (*arrows*)

The pathogenesis was diagnosed as SPE secondary to *S. aureus* septicemia originating from the subcutaneous abscess of the left forearm. Vancomycin was de-escalated to cefazolin (6 g/day) for 11 days following cefaclor treatment (1.5 g/day) for 4 days with drainage of the subcutaneous abscess. The patient showed a good response to the antibiotic therapy; blood cultures detected no bacteria, the subcutaneous abscess in the left forearm epithelized, and the lung cavitary lesions disappeared by 141 days after LDLT.

Discussion {#Sec3}
==========

SPE is defined as the coexistence of multiple lung infiltrates coupled with the isolation of bacteria from the blood and their infection source \[[@CR6], [@CR7]\]. SPE occurs when a thrombus containing bacteria travels to the lung and reaches the pulmonary arteries \[[@CR4], [@CR8]\]. Although it is a rare disorder \[[@CR9]\], SPE is a serious infectious complication that can lead to the development of lung abscesses or bronchopleural fistulae. Moreover, SPE is fatal in up to 13.3 % of patients \[[@CR5], [@CR10]\]. Therefore, early diagnosis and the immediate institution of aggressive antimicrobial treatment are required to overcome SPE \[[@CR11], [@CR12]\].

SPE diagnosis is made in the presence of the following classic features---febrile illness, pulmonary infiltrates, and an extrapulmonary source of infection. Typical respiratory symptoms of SPE include pleuritic chest pain, cough, and hemoptysis \[[@CR4], [@CR5]\]. However, respiratory complaints are not always observed \[[@CR7]\], especially in immunosuppressed patients \[[@CR5]\]. In a chest X-ray, the peripheral and wedge-shaped densities may be suggestive, but in most cases, these findings are not specific \[[@CR13]\] and visible. On the other hand, CT is a more sensitive diagnostic test than chest X-ray \[[@CR14]\]. Therefore, we recommend that chest CT scans should be performed in the presence of clinical features accompanying the isolation of bacteria from the blood and the infectious focus, especially in patients with SPE risk factors such as described below.

The risk factors leading to SPE include intravenous drug abuse, pelvic thrombophlebitis, an immunocompromised state, head and neck infections, endocarditis, and indwelling intravenous catheters \[[@CR4], [@CR5]\]. In the patient reported here, 20-day peripheral continuous intravenous drip therapy had to be performed because of appetite loss during steroid pulse therapy. The identical intravenous catheter had been used during this clinical course. The optimal duration of use of the identical intravenous catheters is controversial \[[@CR15]\], but they should be removed or exchanged earlier to avoid infectious complications including SPE for patients who receive steroid pulse therapy after LDLT.

SPE progresses to a lung abscess rapidly \[[@CR8], [@CR9]\]. In a lung abscess, a localized parenchymal infection becomes necrotic \[[@CR16]\], an abscess with air/fluid level is identified in the lung cavity \[[@CR8], [@CR16]\], the sputum is purulent and, on Gram staining, many bacteria and polymorphonuclear leulocytes are detected. In the present case, no abscess formation was detected in the lung cavities by CT and the sputum was not purulent. Therefore, the pathogenesis was SPE and did not progress to lung abscess.

SPE treatment depends on identifying the source of infection, and choosing the appropriate antimicrobial therapy \[[@CR5]\] at an early stage. One pathogen commonly associated with SPE is *S. aureus* \[[@CR4], [@CR9], [@CR12]\], and methicillin-resistant *S. aureus* (MRSA) strains are often reported \[[@CR4], [@CR9]\]. In the current patient, vancomycin was used as an empiric therapy until the pathogen was identified, as MRSA infections are common after LDLT \[[@CR17]\]. However, vancomycin is not recommended for long-term use because of the selection risk of vancomycin-resistant *S. aureus*. The recently uploaded Surviving Sepsis Campaign Guidelines recommend a treatment strategy involving the use of a broad-spectrum, empirical antimicrobial regimen, followed by a de-escalated, pathogen-specific therapy to lessen the risk of developing antibiotic resistance \[[@CR18], [@CR19]\]. Based on these guidelines, we replaced vancomycin with cefazolin as soon as the pathogen was identified as methicillin-sensitive *S. aureus* in the current patient. Furthermore, when infectious disease occurred after LDLT, the trough level of tacrolimus had to be controlled to prevent excessive immunosuppression. In the present patient, tacrolimus was administered orally and target trough level was 2 ng/ml. However, there were two episodes of over-dosing of tacrolimus during the clinical course, because the patient sometimes had diarrhea after total colectomy. Further strict monitoring of immunosuppressants had to be necessary.

To the best of our knowledge, only one other patient has been reported to suffer from SPE after LDLT \[[@CR20]\]; however, SPE remains one of the more serious infectious complications in immunosuppressed patients. Early diagnosis, drainage of the infection source, and appropriate use of antimicrobial therapy should be necessary to overcome SPE. Furthermore, the identical intravenous catheters should be removed whenever possible to avoid infectious complications including SPE for patients who receive steroid pulse therapy after LDLT.
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